| Opella Healthcare Switzerland AG - Telfastin 180, überzogene Tabletten | | 61283 | | 02 | | Telfastin 180 | | überzogene Tabletten | | R06AX26 | | Fexofenadine | | 24.08.2021 | | |
| | Composition | | fexofenadini hydrochloridum 180 mg, cellulosum microcristallinum, amylum pregelificatum, carmellosum natricum conexum corresp. natrium 0.18 mg, magnesii stearas, Überzug: hypromellosum, polyvidonum K 29-32, E 171, silica colloidalis anhydrica, macrogolum 400, E 172 (rubrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | | | | | Active Agent | Dose |
|---|
| Fexofenadine Hydrochloride | 180 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | | | | | color. | | | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | | | | | | 29-32 | | | | | | | Silica Colloidalis Anhydrica | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 011 | 10 | PR | PR | D | | No |
|
|
